| Mrs Emily Lorenz Boucher, FNP-C | |
|
16000 Johnston Memorial Dr Ste 112, Abingdon, VA 24211-7667 | |
| (276) 258-3780 | |
| Not Available |
| Full Name | Mrs Emily Lorenz Boucher |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Location | 16000 Johnston Memorial Dr Ste 112, Abingdon, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447993985 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 0024182239 (Virginia) | Primary |
| Entity Name | Blue Ridge Medical Management Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326159567 PECOS PAC ID: 9739099441 Enrollment ID: O20040715001336 |
News Archive
GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) (the "Company"), an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced that it has requested a pre-Investigational New Drug (IND) meeting with the U.S. Food and Drug Administration (FDA) to discuss a proposed IND for GeoVax's therapeutic vaccine as a treatment for individuals infected with HIV/AIDS.
The number of people who live at home with Alzheimer's Disease (AD), a brain disease that causes abnormal changes that kill brain cells, is expected to grow from 3.2 million today to more than 8 million in 2050.
As strange as it sounds, a new research study published in the FASEB Journal (http://www.fasebj.org), suggests that the "healthy" ingredient in red wine, resveratrol, may prevent the negative effects that spaceflight and sedentary lifestyles have on people.
Olympus America Inc., a precision technology leader designing and delivering innovative solutions in medical and surgical products among other core business areas, today launched its new V-System. The new V-System combines Olympus' latest duodenoscope, the TJF-Q180V, with its unique V-System devices for the endoscopic retrograde cholangiopancreatography procedure.
Cybersickness, or motion sickness during the use of virtual reality, can be a major roadblock to the development and adoption of augmented and virtual reality technology.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Emily Lorenz Boucher, FNP-C 1021 W Oakland Ave Ste 310, Johnson City, TN 37604-2192 Ph: (423) 302-6565 | Mrs Emily Lorenz Boucher, FNP-C 16000 Johnston Memorial Dr Ste 112, Abingdon, VA 24211-7667 Ph: (276) 258-3780 |
News Archive
GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) (the "Company"), an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced that it has requested a pre-Investigational New Drug (IND) meeting with the U.S. Food and Drug Administration (FDA) to discuss a proposed IND for GeoVax's therapeutic vaccine as a treatment for individuals infected with HIV/AIDS.
The number of people who live at home with Alzheimer's Disease (AD), a brain disease that causes abnormal changes that kill brain cells, is expected to grow from 3.2 million today to more than 8 million in 2050.
As strange as it sounds, a new research study published in the FASEB Journal (http://www.fasebj.org), suggests that the "healthy" ingredient in red wine, resveratrol, may prevent the negative effects that spaceflight and sedentary lifestyles have on people.
Olympus America Inc., a precision technology leader designing and delivering innovative solutions in medical and surgical products among other core business areas, today launched its new V-System. The new V-System combines Olympus' latest duodenoscope, the TJF-Q180V, with its unique V-System devices for the endoscopic retrograde cholangiopancreatography procedure.
Cybersickness, or motion sickness during the use of virtual reality, can be a major roadblock to the development and adoption of augmented and virtual reality technology.
› Verified 9 days ago
Chesley Stanley, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 607 Campus Dr, Abingdon, VA 24210 Phone: 276-525-4603 | |
Matthew J Sykes, ANP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 300 East Valley Street, Abingdon, VA 24210 Phone: 276-628-7600 Fax: 276-628-2629 | |
Dr. Courtney Neel Rogers, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 16000 Johnston Memorial Dr Ste 213, Abingdon, VA 24211 Phone: 276-258-2600 | |
Virginia A. Thurston, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 613 Campus Dr, Suite 200, Abingdon, VA 24210 Phone: 276-628-1186 Fax: 276-628-8507 | |
Rebekah Christine Davis, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 631 Campus Dr, Abingdon, VA 24210 Phone: 276-676-3870 Fax: 276-628-8927 | |
Mrs. Lora Diane Reynolds, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 16000 Johnston Memorial Dr, Suite 313, Abingdon, VA 24211 Phone: 276-258-3780 Fax: 276-258-3776 | |
Dr. Diana Michelle Oakes, DNP FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 16000 Johnston Memorial Dr Ste 312c, Abingdon, VA 24211 Phone: 276-258-1000 |